Jacobs Levy Equity Management’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,650	Closed	-$799K	–	1013
2021 Q3	$799K	Buy	3,650 +360	+11%	+$76.2K	0.01%	798
2021 Q2	$763K	Sell	3,290 -1,075	-25%	-$274K	0.01%	797
2021 Q1	$1.31M	Buy	4,365 +1,181	+37%	+$423K	0.01%	679
2020 Q4	$1.2M	Buy	3,184 +881	+38%	+$309K	0.01%	678
2020 Q3	$707K	Sell	2,303 -588	-20%	-$225K	0.01%	723
2020 Q2	$1.09M	Buy	2,891 +2,035	+238%	+$576K	0.01%	655
2020 Q1	$195K	Buy	856 +302	+55%	+$115K	﹤0.01%	891
2019 Q4	$293K	Buy	+554	New	+$300K	﹤0.01%	858
2017 Q1	–	Sell	-192	Closed	-$117K	–	946
2016 Q4	$117K	Sell	192 -74	-28%	-$46.2K	﹤0.01%	886
2016 Q3	$190K	Sell	266 -21	-7%	-$16.1K	﹤0.01%	917
2016 Q2	$208K	Buy	287 +14	+5%	+$9.65K	﹤0.01%	1005
2016 Q1	$162K	Sell	273 -6	-2%	-$3.08K	﹤0.01%	996
2015 Q4	$160K	Buy	279 +103	+59%	+$68.3K	﹤0.01%	712
2015 Q3	$99K	Sell	176 -121	-41%	-$87.4K	﹤0.01%	761
2015 Q2	$236K	Buy	+297	New	+$246K	﹤0.01%	700